Showing results (291-300 of 366) with videos related to

Sort By:
Pageof 37
Contemporary Clinical Dentistry|January 8, 2013
In vitro antimicrobial activity of mouth washes and herbal products against dental biofilm-forming bacteriaNaiana B Da Silva, Adílis K F Alexandria, Aline L De Lima, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2016
A New Antileishmanial Preparation of Combined Solamargine and Solasonine Heals Cutaneous Leishmaniasis through Different Immunochemical PathwaysC M Lezama-Dávila, J D McChesney, J K Bastos, et al.
Lupus|May 15, 2015
Electroconvulsive therapy as a treatment for refractory neuropsychiatric lupus with catatonia: three case studies and literature reviewB E R G Bica, A L D Moro, V Hax, et al.
Mycoses|September 2, 2020
Acanthamoeba castellanii as an alternative interaction model for the dermatophyte Trichophyton rubrumLucas V de Faria, Paulo H F do Carmo, Marliete C da Costa, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2008
Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphismAysun Karatas, Björn Hegner, Leon J de Windt, et al.
Epilepsy Research|October 1, 1993
Carbamazepine and phenytoin in epilepsies refractory to barbiturates: efficacy, toxicity and mental functionP R Bittencourt, S A Antoniuk, M M Bigarella, et al.
Emerging Infectious Diseases|December 8, 2009
Cross-sectional survey of hantavirus infection, BrazilJean E Limongi, Fabíola C da Costa, Rogério M C Pinto, et al.
Toxins|June 1, 2018
Antimicrobial and Chemotactic Activity of Scorpion-Derived Peptide, ToAP2, against <i>Mycobacterium massiliensis</i>Lázaro M Marques-Neto, Monalisa M Trentini, Rogério C das Neves, et al.
RNA Biology|September 5, 2015
The unique Leishmania EIF4E4 N-terminus is a target for multiple phosphorylation events and participates in critical interactions required for translation initiationOsvaldo P de Melo Neto, Tamara D C da Costa Lima, Camila C Xavier, et al.
Oncogene|January 17, 2017
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cellsS Ros, J Flöter, I Kaymak, et al.
Pageof 37